CDT Equity stock analysis
CDT Equity (CDT) Stock Price & Analysis
CDT Stock Chart & Stats
- Day’s Range
- $0.34 - $0.38
- 52-Week Range
- $0.34 - $291,250.00
- Previous Close
- $0.38
- Volume
- N/A
- Average Volume (3M)
- 1.90M
- Market Cap
- $366.43K
- Enterprise Value
- $1081.45T
- Total Cash (Recent Filing)
- $348.65M
- Total Debt (Recent Filing)
- $1.32B
- Price to Earnings (P/E)
- 0.0
- Beta
- 1.88
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
CDT Equity News
CDT FAQ
What was CDT Equity’s price range in the past 12 months?
What is CDT Equity’s market cap?
When is CDT Equity’s upcoming earnings report date?
Is CDT Equity overvalued?
Does CDT Equity pay dividends?
What is CDT Equity’s EPS estimate?
How many shares outstanding does CDT Equity have?
Which hedge fund is a major shareholder of CDT Equity?
What is the TipRanks Smart Score and how is it calculated?
Company Description
CDT Equity
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jamie Bligh
- Employees
- 4
- Website
- www.cdtequity.com
- Address
- 4581 Tamiami Trail North, Naples, FL, 34103, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 0 | 17 |
| Technical Analysis | 5 | 0 | 5 |
| Moving Averages | 0 | 0 | 12 |












